A Form 4 filed on September 3, 2026, with the U.S. Securities and Exchange Commission reports that Varadarajan Seshasayee, Senior Vice President at Lam Research Corp (NASDAQ:LRCX), disposed of a total of 59,750 shares of common stock and exercised two employee stock option grants on September 2, 2026, all under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Open-market sales: Seshasayee disposed of 59,750 shares of common stock across three separate sale transactions, each at a price of $291.32 per share.
  • Option exercises: He exercised 12,270 options at an exercise price of $59.881 and 27,480 options at an exercise price of $30.033, acquiring the resulting shares before selling them.
  • Post-transaction ownership: Following all reported transactions, Seshasayee directly held 205,546 shares, a figure the filing notes includes shares subject to unvested restricted stock units.
  • Indirect holdings: The filing also reports 2,366.911 shares held indirectly through a 401(k) plan.
  • 10b5-1 plan: All transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Seshasayee on May 4, 2026, according to the filing.
  • Signed by attorney: The form was signed by Marta Woods under power of attorney on September 3, 2026.

Lam Research SVP Reports Option Exercises and Share Sales on September 2, 2026

According to the Form 4 filing, Varadarajan Seshasayee, identified as Senior Vice President of Lam Research Corp, carried out five transactions in the company's common stock on September 2, 2026. The filing indicates that all transactions were made pursuant to a Rule 10b5-1 trading plan that Seshasayee adopted on May 4, 2026.

The filing reports that Seshasayee first sold 20,000 shares at $291.32 per share. He then exercised employee stock options covering 12,270 shares at an exercise price of $59.881, acquiring those shares, and immediately sold 12,270 shares at $291.32. He subsequently exercised a second option grant covering 27,480 shares at an exercise price of $30.033, and sold those 27,480 shares at $291.32 per share. The two option grants are reported in Table II as having zero remaining balance following the transactions.

The filing notes that the 12,270-share option grant was scheduled to become exercisable in three equal installments on March 1, 2022, March 1, 2023, and March 1, 2024, with an expiration date of March 1, 2028. The 27,480-share option grant was scheduled to become exercisable in three equal installments on March 2, 2021, March 2, 2022, and March 2, 2023, with an expiration date of March 2, 2027. After all transactions, the filing reports direct beneficial ownership of 205,546 shares, which the filing states includes shares subject to unvested restricted stock units, plus 2,366.911 shares held indirectly through a 401(k).

What Was Disclosed

The filing discloses that Lam Research Senior Vice President Varadarajan Seshasayee sold 59,750 shares and exercised two stock option grants totaling 39,750 shares on September 2, 2026, all under a pre-adopted Rule 10b5-1 plan, leaving him with direct ownership of 205,546 shares.